Clinical impact of levofloxacin inhalation solution in cystic fibrosis patients in a real-world setting

Carsten Schwarz,Claudia Grehn,Svenja Temming,Frederik Holz,Patience Ndidi Eschenhagen

Journal of Cystic Fibrosis（2021）

引用 6|浏览5

暂无评分

摘要

•Inhaling levofloxacin might increase the FEV1 in people with CF.•Inhaling levofloxacin might reduce the exacerbation rate in people with CF.•Inhaling levofloxacin is well tolerated.

查看译文

关键词

Inhaled antibiotics,Levofloxacin solution,Chronic Pseudomonas aeruginosa infection,exacerbation rate,Pulmonary function test

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要